Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Non-Current Assets (2020 - 2025)

Journey Medical (DERM) has disclosed Non-Current Assets for 6 consecutive years, with $28.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Assets rose 61.08% year-over-year to $28.8 million, compared with a TTM value of $121.7 million through Sep 2025, up 59.02%, and an annual FY2024 reading of $32.1 million, up 57.21% over the prior year.
  • Non-Current Assets was $28.8 million for Q3 2025 at Journey Medical, down from $29.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $35.1 million in Q1 2023 and bottomed at $12.8 million in Q4 2021.
  • Average Non-Current Assets over 5 years is $25.2 million, with a median of $27.5 million recorded in 2022.
  • The sharpest move saw Non-Current Assets skyrocketed 114.85% in 2022, then plummeted 44.33% in 2024.
  • Year by year, Non-Current Assets stood at $12.8 million in 2021, then skyrocketed by 114.85% to $27.5 million in 2022, then dropped by 25.79% to $20.4 million in 2023, then soared by 57.21% to $32.1 million in 2024, then fell by 10.16% to $28.8 million in 2025.
  • Business Quant data shows Non-Current Assets for DERM at $28.8 million in Q3 2025, $29.9 million in Q2 2025, and $31.0 million in Q1 2025.